News

In this interview, Dr. Michelle Longmire, CEO of Medable, will discuss her perspective on the advancements of digital health in clinical trials.

As the EMA celebrates its 2017 highlights, the new year brings deeper challenges for the agency-including preserving the credibility of its patient-first mission.

This article discusses real-time data capture and analytics in clinical trials.

A sex-bias that significantly impacts the advancement of women’s health exists in both preclinical and clinical research.

With the pharmaceutical industry looking for new investigators, a non-commercial clinical trial has become an under appreciated source.

Kristy Galante, Director Process and Infrastructure of External Alliances at Janssen, recently spoke about a novel vendor oversight model at ExL’s 8th Clinical Quality Oversight Forum, and will expand on the model in this interview.

Updated employee announcements, business news, awards, and recognition in the industry today.

Case study shows that site activation is a key driver in determining patient enrollment cycle time, which can be minimized by identifying the "sweet spot" of sites to deploy for a clinical trial.

Case study demonstrates that site activation is a key driver in determining patient enrollment cycle time.

A data analysis focusing on where US investigators conduct clinical trials.

Examining the main challenges in designing and executing MS clinical trials and proposing mitigation strategies that may help alleviate these burdens.